Trial Details

Not Recruiting
Basic Information
Clinical ID c5069
Identifier EUCTR2019-002070-31-DK
Trial Title Adherence of a 1.600 mg single tablet 5-ASA treatment of Ulcerative colitis (EASI-trial)
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Ulcerative colitis (UC) belongs to the group of inflammatory bowel diseases. The disease course is unpredictable and characterised by chronic inflammation of the colonic mucosa, where acute attacks are followed by periods of remission. Development of UC i
Interventions Trade Name: ASACOLPharmaceutical Form: TabletINN or Proposed INN: MESALAZINECAS Number: 89-57-6Concentration unit: mg milligram(s)Concentration type: rangeConcentration number: 1600-4800
Participant Information
Sponsor Copenhagen University Hospital Hvidovre
City NULL
Country/Region Denmark
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement NULL
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL